AC Immune SA (IMR) Financial Statements
AC Immune SA Financial Overview
AC Immune SA's market cap is currently $201.63M. The company's EPS TTM is $-0.43; its P/E ratio is -4.25; AC Immune SA is scheduled to report earnings on November 10, 2026, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.57M | $ 27.31M | $ 14.80M | $ 3.94M | $ 0.00 |
| Gross Profit | $ 3.57M | $ -35.26M | $ -39.80M | $ 3.94M | $ 0.00 |
| Operating Income | $ -68.86M | $ -52.38M | $ -53.62M | $ -70.85M | $ -79.01M |
| EBITDA | $ -67.75M | $ -48.62M | $ -51.83M | $ -68.03M | $ -70.01M |
| Net Income | $ -70.45M | $ -50.92M | $ -54.23M | $ -70.75M | $ -73.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 91.41M | $ 165.49M | $ 103.05M | $ 122.59M | $ 198.22M |
| Total Assets | $ 154.43M | $ 230.91M | $ 182.81M | $ 185.94M | $ 261.44M |
| Total Debt | $ 4.55M | $ 5.43M | $ 3.50M | $ 2.80M | $ 2.91M |
| Net Debt | $ -22.28M | $ -30.85M | $ -75.00M | $ -28.79M | $ -79.31M |
| Total Liabilities | $ 109.49M | $ 118.64M | $ 22.17M | $ 16.95M | $ 29.46M |
| Stockholders' Equity | $ 44.93M | $ 112.27M | $ 160.64M | $ 168.99M | $ 231.98M |
| Cash Flow | |||||
| Free Cash Flow | $ -67.01M | $ 65.27M | $ -61.21M | $ -74.81M | $ -68.32M |
| Operating Cash Flow | $ -66.15M | $ 65.84M | $ -60.41M | $ -73.57M | $ -65.69M |
| Investing Cash Flow | $ 60.69M | $ -105.29M | $ 65.64M | $ 23.76M | $ -53.66M |
| Financing Cash Flow | $ -974.14K | $ -1.12M | $ 43.25M | $ -1.35M | $ 40.75M |
Currency in CHF